SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-027596
Filing Date
2023-10-04
Accepted
2023-10-04 06:55:16
Documents
14
Period of Report
2023-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20230929_8k.htm   iXBRL 8-K 26063
2 EXHIBIT 99.1 ex_575230.htm EX-99.1 21999
  Complete submission text file 0001437749-23-027596.txt   189306

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eton-20231004.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20231004_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20231004_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20231004_pre.xml EX-101.PRE 12019
8 EXTRACTED XBRL INSTANCE DOCUMENT eton20230929_8k_htm.xml XML 2663
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 231306551
SIC: 2834 Pharmaceutical Preparations